Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration

被引:74
|
作者
Behringer, Karolin [1 ]
Goergen, Helen [1 ]
Mueller, Horst [1 ]
Thielen, Indra [1 ]
Brillant, Corinne [1 ]
Kreissl, Stefanie [1 ]
Halbsguth, Teresa Veronika [3 ]
Meissner, Julia [4 ]
Greil, Richard [6 ]
Moosmann, Peter [7 ,8 ]
Shonukan, Oluwatoyin [9 ]
Rueffer, Jens Ulrich [2 ]
Flechtner, Hans-Henning [5 ]
Fuchs, Michael [1 ]
Diehl, Volker [1 ]
Engert, Andreas [1 ]
Borchmann, Peter [1 ]
机构
[1] Univ Hosp Cologne, Cologne, Germany
[2] German Fatigue Soc, Cologne, Germany
[3] Univ Hosp Frankfurt, Frankfurt, Germany
[4] Heidelberg Univ, Heidelberg, Germany
[5] Otto von Guericke Univ, Magdeburg, Germany
[6] Paracelsus Med Univ, Salzburg, Austria
[7] Cantonal Hosp Aarau AG, Aarau, Switzerland
[8] Swiss Grp Clin Canc Res, Bern, Switzerland
[9] Boston Univ, Sch Publ Hlth, Boston, MA USA
关键词
QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; NON-INFERIORITY TRIAL; DISEASE SURVIVORS; CLINICAL-TRIALS; BREAST-CANCER; OPEN-LABEL; EXERCISE; ONCOLOGY;
D O I
10.1200/JCO.2016.67.7450
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Cancer-related fatigue occurs frequently in patients with Hodgkin lymphoma (HL) and has a major impact on their quality of life. We hypothesized that severe fatigue (sFA) might have an impact on patients' treatment outcome and social reintegration. Methods Of 5,306 patients enrolled in the German Hodgkin Study Group's fifth generation of clinical trials in HL (HD13, HD14, and HD15; nonqualified and older [>60 years] patients excluded), 4,529 provided data on health-related quality of life. We describe sFA (defined as a score >= 50 on the 0 to 100 scale from the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30) before and up to 9 years after therapy and analyze its impact on treatment outcome and social reintegration. Results The proportion of patients reporting sFA was 37% at baseline and ranged from 20% to 24% during follow-up. Baseline sFA was associated with significantly impaired progression-free survival and a trend to impaired overall survival, which can be overcome in patients receiving highly effective HL therapies as applied in our fifth-generation trials. Our analysis revealed a significant negative association of sFA and employment in survivors: 5 years after therapy, 51% and 63% of female and male survivors, respectively, with sFA were working or in professional education, compared with 78% and 90% without sFA, respectively (P < .001 adjusted for age, sex, stage, baseline employment status, and treatment outcome). sFA was also associated with financial problems and the number of visits to a general practitioner and medical specialists. Conclusion sFA is an important factor preventing survivors from social reintegration during follow-up. This observation underscores the need to address fatigue as a significant diagnosis when treating patients with and survivors of cancer. (C) 2016 by American Society of Clinical Oncology
引用
收藏
页码:4329 / +
页数:17
相关论文
共 50 条
  • [31] Cancer-related and treatment-related fatigue
    Wang, Xin Shelley
    Woodruff, Jeanie F.
    GYNECOLOGIC ONCOLOGY, 2015, 136 (03) : 446 - 452
  • [32] Cancer-related fatigue treatment: An overview
    Mohandas, Hemanth
    Jaganathan, Saravana Kumar
    Mani, Mohan Prasath
    Ayyar, Manikandan
    Thevi, G. V. Rohini
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (06) : 916 - 929
  • [33] Treatment of cancer-related fatigue: an update
    Escalante, CP
    SUPPORTIVE CARE IN CANCER, 2003, 11 (02) : 79 - 83
  • [34] Pharmacologic treatment of cancer-related fatigue
    Carroll, Jennifer K.
    Kohli, Sadhna
    Mustian, Karen M.
    Roscoe, Joseph A.
    Morrow, Gary R.
    ONCOLOGIST, 2007, 12 : 43 - 51
  • [35] Cancer-Related Fatigue: The Approach and Treatment
    Escalante, Carmen P.
    Manzullo, Ellen F.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 412 - 416
  • [36] Treatment of cancer-related fatigue: an update
    Carmen P. Escalante
    Supportive Care in Cancer, 2003, 11 : 79 - 83
  • [37] Assessment and treatment of cancer-related fatigue
    Blickle, Patricia
    Schmidt, Martina E.
    Steindorf, Karen
    ONKOLOGIE, 2024, : 548 - 555
  • [38] Modafinil for the treatment of cancer-related fatigue
    Wirz, S.
    Nadstawek, J.
    Kuehn, K. U.
    Vater, S.
    Junker, U.
    Wartenberg, H. C.
    SCHMERZ, 2010, 24 (06): : 587 - 595
  • [39] Cancer-Related Fatigue: The Approach and Treatment
    Carmen P. Escalante
    Ellen F. Manzullo
    Journal of General Internal Medicine, 2009, 24 : 412 - 416
  • [40] Web-Based Cognitive-Behavioral Therapy to Reduce Severe Cancer-Related Fatigue Among Survivors of Hodgkin Lymphoma: A Feasibility Study
    Esser, Peter
    Mueller, Horst
    Borchmann, Peter
    Kreissl, Stefanie
    Knoop, Hans
    Platzbecker, Uwe
    Vucinic, Vladan
    Mehnert-Theuerkauf, Anja
    JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS, 2023, 30 (04) : 856 - 865